Insmed Incorporated - Common Stock (NQ:INSM)
110.34
-5.27
(-4.56%)
Streaming Delayed Price
Updated: 11:04 AM EDT, Jul 13, 2026
Add to My Watchlist
Price and Volume
Detailed Quote| Volume | 738,529 |
| Open | 114.25 |
| Bid (Size) | 110.04 (100) |
| Ask (Size) | 110.67 (100) |
| Prev. Close | 115.61 |
| Today's Range | 109.39 - 115.55 |
| 52wk Range | 90.39 - 212.75 |
| Shares Outstanding | 115,246,666 |
| Dividend Yield | N/A |
Top News
More News
Monday's after hours session: top gainers and losers ↗
July 06, 2026
Tuesday's after hours session: top gainers and losers ↗
June 23, 2026
Performance
More News
Read More
Insmed (INSM) Q1 2026 Earnings Transcript ↗
May 07, 2026
Insmed (INSM) Q4 2025 Earnings Call Transcript ↗
February 19, 2026
Frequently Asked Questions
Is Insmed Incorporated - Common Stock publicly traded?
Yes, Insmed Incorporated - Common Stock is publicly traded.
What exchange does Insmed Incorporated - Common Stock trade on?
Insmed Incorporated - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Insmed Incorporated - Common Stock?
The ticker symbol for Insmed Incorporated - Common Stock is INSM on the Nasdaq Stock Market
What is the current price of Insmed Incorporated - Common Stock?
The current price of Insmed Incorporated - Common Stock is 110.34
When was Insmed Incorporated - Common Stock last traded?
The last trade of Insmed Incorporated - Common Stock was at 07/13/26 11:04 AM ET
What is the market capitalization of Insmed Incorporated - Common Stock?
The market capitalization of Insmed Incorporated - Common Stock is 12.72B
How many shares of Insmed Incorporated - Common Stock are outstanding?
Insmed Incorporated - Common Stock has 13B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
Facebook
Twitter
YouTube